vs

Side-by-side financial comparison of Healthcare Realty Trust Inc (HR) and Penumbra Inc (PEN). Click either name above to swap in a different company.

Penumbra Inc is the larger business by last-quarter revenue ($385.4M vs $279.0M, roughly 1.4× Healthcare Realty Trust Inc). Penumbra Inc runs the higher net margin — 12.3% vs -0.0%, a 12.3% gap on every dollar of revenue. On growth, Penumbra Inc posted the faster year-over-year revenue change (22.1% vs 5.9%). Over the past eight quarters, Penumbra Inc's revenue compounded faster (17.6% CAGR vs -6.1%).

Duke Realty was a real estate investment trust (REIT) based in Indianapolis, Indiana, that invested in industrial properties. As of December 31, 2021, it owned or jointly controlled 548 primarily industrial properties containing 162.7 million rentable square feet. In October 2022, it was acquired by Prologis.

Penumbra, Inc. is an American medical device company headquartered in Alameda, California. The company was founded by Arani Bose and Adam Elsesser in 2004. It manufactures devices for interventional therapies to treat vascular conditions such as stroke and aneurysm.

HR vs PEN — Head-to-Head

Bigger by revenue
PEN
PEN
1.4× larger
PEN
$385.4M
$279.0M
HR
Growing faster (revenue YoY)
PEN
PEN
+16.2% gap
PEN
22.1%
5.9%
HR
Higher net margin
PEN
PEN
12.3% more per $
PEN
12.3%
-0.0%
HR
Faster 2-yr revenue CAGR
PEN
PEN
Annualised
PEN
17.6%
-6.1%
HR

Income Statement — Q1 FY2026 vs Q4 FY2025

Metric
HR
HR
PEN
PEN
Revenue
$279.0M
$385.4M
Net Profit
$-56.0K
$47.3M
Gross Margin
68.0%
Operating Margin
15.4%
Net Margin
-0.0%
12.3%
Revenue YoY
5.9%
22.1%
Net Profit YoY
40.6%
EPS (diluted)
$0.00
$1.20

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
HR
HR
PEN
PEN
Q1 26
$279.0M
Q4 25
$286.3M
$385.4M
Q3 25
$297.8M
$354.7M
Q2 25
$297.5M
$339.5M
Q1 25
$299.0M
$324.1M
Q4 24
$309.8M
$315.5M
Q3 24
$315.4M
$301.0M
Q2 24
$316.3M
$299.4M
Net Profit
HR
HR
PEN
PEN
Q1 26
$-56.0K
Q4 25
$14.6M
$47.3M
Q3 25
$-57.7M
$45.9M
Q2 25
$-157.9M
$45.3M
Q1 25
$-44.9M
$39.2M
Q4 24
$-108.2M
$33.7M
Q3 24
$-93.0M
$29.5M
Q2 24
$-143.8M
$-60.2M
Gross Margin
HR
HR
PEN
PEN
Q1 26
Q4 25
68.0%
Q3 25
67.8%
Q2 25
66.0%
Q1 25
66.6%
Q4 24
66.8%
Q3 24
66.5%
Q2 24
54.4%
Operating Margin
HR
HR
PEN
PEN
Q1 26
Q4 25
15.4%
Q3 25
13.8%
Q2 25
12.0%
Q1 25
12.4%
Q4 24
13.6%
Q3 24
11.7%
Q2 24
-27.0%
Net Margin
HR
HR
PEN
PEN
Q1 26
-0.0%
Q4 25
183.4%
12.3%
Q3 25
-19.4%
12.9%
Q2 25
-53.1%
13.3%
Q1 25
-15.0%
12.1%
Q4 24
-1924.1%
10.7%
Q3 24
-29.5%
9.8%
Q2 24
-45.5%
-20.1%
EPS (diluted)
HR
HR
PEN
PEN
Q1 26
$0.00
Q4 25
$0.04
$1.20
Q3 25
$-0.17
$1.17
Q2 25
$-0.45
$1.15
Q1 25
$-0.13
$1.00
Q4 24
$-0.34
$0.88
Q3 24
$-0.26
$0.75
Q2 24
$-0.39
$-1.55

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
HR
HR
PEN
PEN
Cash + ST InvestmentsLiquidity on hand
$26.2M
$186.9M
Total DebtLower is stronger
Stockholders' EquityBook value
$4.4B
$1.4B
Total Assets
$9.1B
$1.8B
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
HR
HR
PEN
PEN
Q1 26
$26.2M
Q4 25
$26.2M
$186.9M
Q3 25
$43.3M
$321.0M
Q2 25
$25.5M
$421.8M
Q1 25
$25.7M
$376.1M
Q4 24
$68.9M
$324.4M
Q3 24
$22.8M
$280.5M
Q2 24
$41.8M
$288.3M
Total Debt
HR
HR
PEN
PEN
Q1 26
Q4 25
$3.9B
Q3 25
$4.5B
Q2 25
$4.7B
Q1 25
$4.7B
Q4 24
$4.7B
Q3 24
$5.0B
Q2 24
$5.1B
Stockholders' Equity
HR
HR
PEN
PEN
Q1 26
$4.4B
Q4 25
$4.6B
$1.4B
Q3 25
$4.7B
$1.4B
Q2 25
$4.8B
$1.3B
Q1 25
$5.1B
$1.2B
Q4 24
$5.2B
$1.2B
Q3 24
$5.5B
$1.1B
Q2 24
$5.9B
$1.2B
Total Assets
HR
HR
PEN
PEN
Q1 26
$9.1B
Q4 25
$9.2B
$1.8B
Q3 25
$9.9B
$1.7B
Q2 25
$10.2B
$1.7B
Q1 25
$10.5B
$1.6B
Q4 24
$10.7B
$1.5B
Q3 24
$11.2B
$1.5B
Q2 24
$11.8B
$1.5B
Debt / Equity
HR
HR
PEN
PEN
Q1 26
Q4 25
0.85×
Q3 25
0.96×
Q2 25
0.97×
Q1 25
0.93×
Q4 24
0.89×
Q3 24
0.90×
Q2 24
0.87×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
HR
HR
PEN
PEN
Operating Cash FlowLast quarter
$86.5M
Free Cash FlowOCF − Capex
$68.0M
FCF MarginFCF / Revenue
17.7%
Capex IntensityCapex / Revenue
9.7%
4.8%
Cash ConversionOCF / Net Profit
1.83×
TTM Free Cash FlowTrailing 4 quarters
$174.9M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
HR
HR
PEN
PEN
Q1 26
Q4 25
$457.1M
$86.5M
Q3 25
$113.8M
$58.3M
Q2 25
$163.2M
$44.9M
Q1 25
$47.8M
$49.0M
Q4 24
$501.6M
$51.1M
Q3 24
$119.3M
$56.5M
Q2 24
$168.2M
$22.6M
Free Cash Flow
HR
HR
PEN
PEN
Q1 26
Q4 25
$68.0M
Q3 25
$42.0M
Q2 25
$29.4M
Q1 25
$35.5M
Q4 24
$45.7M
Q3 24
$51.0M
Q2 24
$18.1M
FCF Margin
HR
HR
PEN
PEN
Q1 26
Q4 25
17.7%
Q3 25
11.8%
Q2 25
8.7%
Q1 25
11.0%
Q4 24
14.5%
Q3 24
16.9%
Q2 24
6.0%
Capex Intensity
HR
HR
PEN
PEN
Q1 26
9.7%
Q4 25
4.8%
Q3 25
4.6%
Q2 25
4.6%
Q1 25
4.2%
Q4 24
1.7%
Q3 24
1.8%
Q2 24
1.5%
Cash Conversion
HR
HR
PEN
PEN
Q1 26
Q4 25
31.33×
1.83×
Q3 25
1.27×
Q2 25
0.99×
Q1 25
1.25×
Q4 24
1.52×
Q3 24
1.91×
Q2 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

HR
HR

Rental income$267.6M96%
Other$11.4M4%

PEN
PEN

Thrombectomy$254.7M66%
Other$130.7M34%

Related Comparisons